Literature DB >> 7196603

Echocardiography in combined discrete and hypertrophic subaortic stenosis.

R Charles, C Makin, N Coulshed, D Hamilton.   

Abstract

A 10-year-old boy with discrete subaortic stenosis had coexisting abnormal systolic anterior motion of the mitral valve, demonstrated by echocardiography, a sign normally taken as indicating the presence of idiopathic hypertrophic subaortic stenosis. Surgical removal of a fibromuscular diaphragm abolished the echocardiographic signs of discrete subaortic stenosis but abnormal systolic anterior motion of the mitral valve persisted. A severe low cardiac output state complicated immediate recovery after removal of the left ventricle outflow obstruction, and was overcome only with considerable difficulty. The presence of hypertrophied septal muscle, and the associated small left ventricular cavity size, was thought to be the immediate cause of these problems, so that recognition of marked septal hypertrophy, together with abnormal anterior systolic movement of the mitral valve, should serve as a warning that similar difficulties are likely to bae encountered by other patients, after removal of the obstruction in subaortic stenosis. In our experience other forms of left ventricle outflow tract obstruction have not been found to show such a marked degree of asymmetric septal hypertrophy, but this does not mean it may not occur.

Entities:  

Mesh:

Year:  1981        PMID: 7196603      PMCID: PMC471455          DOI: 10.1136/thx.36.2.126

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  10 in total

1.  Membranous subaortic stenosis complicated by aneurysm of the membranous septum and mitral valve prolapse.

Authors:  C C Caudill; S K Krueger; C S Wilson; T Rourke; D B Policky; W F Weaver
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

2.  Echocardiography in coexisting hypertrophic subaortic stenosis and fixed left ventricular outflow obstruction.

Authors:  K J Chung; J A Manning; R Gramiak
Journal:  Circulation       Date:  1974-04       Impact factor: 29.690

3.  Ventricular systolic septal thickening and excursion in idiopathic hypertrophic subaortic stenosis.

Authors:  R M Rossen; D J Goodman; R E Ingham; R L Popp
Journal:  N Engl J Med       Date:  1974-12-19       Impact factor: 91.245

4.  Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS.

Authors:  W L Henry; C E Clark; S E Epstein
Journal:  Circulation       Date:  1973-02       Impact factor: 29.690

5.  Coexistent fixed congenital and idiopathic hypertrophic subaortic stenosis.

Authors:  P C Block; W J Powell; R E Dinsmore; A Goldblatt
Journal:  Am J Cardiol       Date:  1973-04       Impact factor: 2.778

6.  Echocardiographic findings in discrete subvalvular aortic stenosis.

Authors:  R L Popp; J F Silverman; J W French; E B Stinson; D C Harrison
Journal:  Circulation       Date:  1974-02       Impact factor: 29.690

7.  Echocardiographic manifestations of discrete subaortic stenosis.

Authors:  R H Davis; H Feigenbaum; S Chang; L L Konecke; J C Dillon
Journal:  Am J Cardiol       Date:  1974-02       Impact factor: 2.778

8.  Discrete subaortic stenosis.

Authors:  D T Kelly; E Wulfsberg; R D Rowe
Journal:  Circulation       Date:  1972-08       Impact factor: 29.690

9.  Echocardiography in discrete subaortic stenosis.

Authors:  S K Krueger; J W French; A D Forker; C C Caudill; R L Popp
Journal:  Circulation       Date:  1979-03       Impact factor: 29.690

Review 10.  Discrete membranous subaortic stenosis. Report of 31 patients, review of the literature, and delineation of management.

Authors:  N M Katz; M J Buckley; R R Liberthson
Journal:  Circulation       Date:  1977-12       Impact factor: 29.690

  10 in total
  1 in total

Review 1.  Subvalvular aortic stenosis: a review of current literature.

Authors:  Subodh R Devabhaktuni; Eyas Chakfeh; Ali O Malik; Joshua A Pengson; Jibran Rana; Chowdhury H Ahsan
Journal:  Clin Cardiol       Date:  2018-01-29       Impact factor: 2.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.